# Neurodegenerative Treatment Factors Diagram

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/d55-png-factors-to-consider-when-treating-neurodegenerative-diseases/
> **Published:** 2026-09-04T23:01:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-13T14:40:39-04:00
> **Clinical Summary:** The factors to weigh when cannabis is considered for Alzheimer's, Parkinson's, multiple sclerosis, or ALS, with summary notes.

---

[← Back to the Palliative Care Summary Hub](https://cedclinic.com/topic-palliative-care/)Diagram & referenceA visual reference. The evidence, sources and clinical interpretation are in the linked article.About this diagramA hub and spoke diagram with neurodegenerative disease at the center and five labeled spokes. The spokes name the variables that separate one cannabinoid product from another: onset timing, short acting versus longer lasting, daytime or nighttime use, product comparison, and euphoric versus non euphoric. The picture ranks nothing, so use it as a checklist of what to settle before comparing products.The evidence behind it[Read the evidence: what cannabis has been tested for in Parkinson’s, Alzheimer’s, Huntington’s and motor neuron disease](https://cedclinic.com/cannabis-for-neurodegenerative-disease-trials/)That article carries the cited studies, the limits of the evidence, and the clinical interpretation.

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).